首页> 外文期刊>International Journal of Surgery Case Reports >Case Report Unexplained isolated acute severe thrombocytopenia after surgery for a recurrent malignant retroperitoneal tumor presenting with colon perforation: A case study of a disastrous complication
【24h】

Case Report Unexplained isolated acute severe thrombocytopenia after surgery for a recurrent malignant retroperitoneal tumor presenting with colon perforation: A case study of a disastrous complication

机译:案例报告未解释的分离急性严重血小板减少术治疗结肠穿孔的复发性恶性腹膜肿瘤术后:一种灾难性并发症的案例研究

获取原文
           

摘要

Introduction Tumor- or treatment- induced thrombocytopenia in solid cancer patients is common. In the postoperative setting, diagnosis of thrombocytopenia become more complex as infection, sepsis, drugs and transfusion come also into the equation. Presentation of case Herein, the case an otherwise-healthy 71-year-old male patient with a sizable recurrent malignant retroperitoneal tumor under pazopanib admitted with colon perforation and submitted to emergency left colectomy with end transverse colostomy is presented. Immediate postoperative period characterized by massive primary tumor growth and isolated acute severe thrombocytopenia. The patient treated with combined prednisone, IVIg and platelets transfusion along with medication discontinuation with no response. Discussion Sepsis-, drug- and heparin-induced thrombocytopenia, disseminated intravascular coagulopathy and secondary (sepsis-, drug-, transfusion- or tumor-induced) immune thrombocytopenia (ITP) were included in the differential diagnosis. Based on exclusion, secondary drug- or tumor-induced ITP was the most prominent diagnosis. Concomitant presentation of thrombocytopenia along with massive primary tumor growth made Kasabach-Merritt syndrome also a probable diagnosis. However, neither secondary ITP nor Kasabach-Merritt syndrome has previously been associated with a retroperitoneal tumor in the literature. Conclusion Although management of thrombocytopenia depends on etiology, in our patient’s case the diagnosis of secondary ITP and directed management did not result in a successful outcome.
机译:引入肿瘤或治疗诱导的血小板减少血小阴性腺癌患者是常见的。在术后设定中,血小板减少症的诊断变得更加复杂,因为感染,败血症,药物和输血也进入了等式。介绍了本文的案例,呈现出在亚拓穿孔的Pazopanib下具有相当健康的71岁男性患者的其他健康的71岁男性患者,并提出了与结肠横向骨细胞造口术治疗紧急结肠切除术。立即术后时期,其特征在于大规模原发性肿瘤生长和分离急性严重血小板减少症。用组合泼尼松,IVIG和血小板输血治疗的患者随附不响应。讨论脓毒症,药物和肝素诱导的血小板减少症,弥散血管内凝血病和继发(脓毒症,药物,输血或肿瘤诱导的)免疫血小板减少症(ITP)被纳入鉴别诊断。基于排斥,二次药物或肿瘤诱导的ITP是最突出的诊断。伴随血小板减少症以及大规模的原发性肿瘤生长制备了Kasabach-Merritt综合征也可能诊断。然而,二级ITP和Kasabach-Merritt综合征之前,先前没有与文献中的腹膜瘤相关联。结论虽然血小板减少症的管理取决于病因,但在我们的患者的情况下,次级ITP和定向管理的诊断不会导致成功的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号